A clear-eyed read of the Cochrane market: where prices sit, how supply and demand balance, and what the 2026 to 2031 window realistically looks like for a buyer today.
Cochrane is a city-fringe market priced well below the TRX precinct one stop away. Entry pricing for new freehold stock starts around RM1,112 psf, with project averages near RM978 psf, against RM1,900 psf and up inside TRX itself.
| Segment | Indicative psf |
|---|---|
| New condo inside TRX | RM1,900 to 2,200 |
| New freehold, Cochrane (average) | ~RM978 |
| New freehold, Cochrane (entry) | ~RM1,112 |
Indicative 2026 ranges; actual pricing varies by project, unit and facing.
The corridor has seen active new launches, so supply is a real factor to weigh. That said, freehold parcels within walking distance of an MRT station are genuinely scarce, which differentiates the best-located stock from the broader pipeline. Supply pressure is felt most by generic, poorly located or leasehold units; well-placed freehold tends to hold better.
Demand is anchored by the TRX jobs cluster, the Monash KL campus, dense retail employment and a hospital catchment, a layered base detailed in our rental demand analysis. Owner-occupier demand is supported by the same connectivity and amenity density.
The single most important dynamic is the psf gap to TRX. As TRX matures, the reasonable expectation is that a well-connected, one-stop-away location captures part of that uplift over time, while entering at a far lower cost base. This is the core thesis in condos near TRX. It is an expectation, not a certainty, and depends on TRX delivering to plan.
Near term, expect the market to digest new supply, which favours patient buyers who choose location and layout carefully over those chasing the cheapest headline. Medium term, the completion of TRX infrastructure, the Monash campus and the wider corridor supports the case for the best-located freehold stock. Anyone buying now is buying a 2031-completion asset, so this is a hold-through-construction play, not a quick flip. The pipeline behind the thesis is in future developments around Cochrane.
The best expression of this analysis is a freehold, walk-to-MRT home bought at the low end of the psf range. That points to Cochrane Residence, from RM721,800, with an independent view in the Binastra Cochrane review.
See current pricing and the units that fit this thesis, from RM721,800.
New freehold stock averages near RM978 psf, from about RM1,112 psf at entry, well below TRX pricing one stop away.
The corridor has active new launches, but freehold parcels near the MRT are scarce; well-located freehold stock is better insulated than generic supply.
Near term the market digests supply; medium term, TRX and corridor infrastructure support the best-located freehold. Buying now is a hold-through-construction position.